Development of a Method for Identification and Quantification of Sulfadiazine and Pyrimethamine in Serum of Congenital Toxoplasmosis Pediatric Patients
JavaScript is disabled for your browser. Some features of this site may not work without it.
Development of a Method for Identification and Quantification of Sulfadiazine and Pyrimethamine in Serum of Congenital Toxoplasmosis Pediatric Patients
Maria Elena Marson1,2,3*, Fleitas Ulises1,2,3, Pérez Montilla Carlos4, Prospitti Anabela1,2, Altcheh Jaime3,4, Moroni Samanta4, Moscatelli Guillermo3,4, García Bournissen Facundo5, Mastrantonio Guido1,2,3